Tempest Therapeutics, Inc. Notes Payable, Current
Tempest Therapeutics, Inc. (TPST) had Notes Payable, Current of $3.50 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:NotesPayableCurrent · last filed 2022-11-08
- 2022-09-30: Notes Payable, Current $3.50M.
- 2022-06-30: Notes Payable, Current $2.00M.
- 2021-12-31: Notes Payable, Current $0.00.
| Period end | Notes Payable, Current |
|---|---|
| 2022-09-30 | $3.50M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.00M 10-Q · filed 2022-08-15 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |